Cancer is caused by mutations in oncogenes and tumor suppressor genes, resulting in the deregulation of processes fundamental to the normal behavior of cells. The identification and characterization of oncogenes and tumor suppressors has led to new treatment strategies that have significantly improved cancer outcome. The advent of next generation sequencing has allowed the elucidation of the fine structure of cancer genomes, however, the identification of pathogenic changes is complicated by the inherent genomic instability of cancer cells. Therefore, functional approaches for the identification of novel genes involved in the initiation and development of tumors are critical. Here we report the first whole human genome in vivo RNA interference screen to identify functionally important tumor suppressor genes. Using our novel approach, we identify previously validated tumor suppressor genes including TP53 and MNT, as well as several novel candidate tumor suppressor genes including leukemia inhibitory factor receptor (LIFR). We show that LIFR is a key novel tumor suppressor, whose deregulation may drive the transformation of a significant proportion of human breast cancers. These results demonstrate the power of genome wide in vivo RNAi screens as a method for identifying novel genes regulating tumorigenesis.
Leukemia inhibitory factor receptor Tumor suppressor gene In vivo RNA interference screen Breast cancer
The authors wish to thank Dr. Tan Ince for providing the HME and HMLE cell lines used in this study. This study was supported in part by grant BC096628 from the DOD, US Congressionally Directed Medical Research Program (to EI).
Conflict of interest
The authors declare that they have no conflict of interest.
Malkin D et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238PubMedCrossRefGoogle Scholar
Prosser J, Thompson AM, Cranston G, Evans HJ (1990) Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene 5:1573–1579PubMedGoogle Scholar
Hurlin PJ et al (2003) Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J 22:4584–4596PubMedCrossRefGoogle Scholar
Toyo-oka K et al (2006) Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. Cancer Res 66:5565–5573PubMedCrossRefGoogle Scholar
Echeverri CJ et al (2006) Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 3:777–779PubMedCrossRefGoogle Scholar
Man D et al (2003) Solution structure of the C-terminal domain of the ciliary neurotrophic factor (CNTF) receptor and ligand free associations among components of the CNTF receptor complex. J Biol Chem 278:23285–23294PubMedCrossRefGoogle Scholar
Wang L, Tu Z, Sun F (2009) A network-based integrative approach to prioritize reliable hits from multiple genome-wide RNAi screens in Drosophila. BMC Genomics 10:220PubMedCrossRefGoogle Scholar
Kritikou EA et al (2003) A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 130:3459–3468PubMedCrossRefGoogle Scholar
Zender L et al (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135:852–864PubMedCrossRefGoogle Scholar
Zhao H et al (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15:2523–2536PubMedCrossRefGoogle Scholar
Bric A et al (2009) Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16:324–335PubMedCrossRefGoogle Scholar
Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT (2009) In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet 41:1133–1137PubMedCrossRefGoogle Scholar
Sorlie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCrossRefGoogle Scholar
Sorlie T et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423PubMedCrossRefGoogle Scholar
Turashvili G et al (2007) Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7:55PubMedCrossRefGoogle Scholar